Filing Details
- Accession Number:
- 0001144204-13-015638
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-18 11:11:12
- Reporting Period:
- 2013-03-15
- Filing Date:
- 2013-03-18
- Accepted Time:
- 2013-03-18 11:11:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 810509 | Navidea Biopharmaceuticals Inc. | NAVB | In Vitro & In Vivo Diagnostic Substances (2835) | 311080091 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559381 | J. William Regan | 425 Metro Place North Suite 450 Dublin OH 43017 | Svp-Global Regulatory Strategy | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-15 | 5,000 | $2.71 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
